Shionogi receives FDA approval for cUTI drug

Japan based Shionogi & Co., Ltd. has announced the U.S. Food and Drug Administration (FDA) has approved FETROJA®...

November 26, 2019 | Tuesday | News
Eisai launches Parkinson's drug in Japan

Tokyo headquartered Eisai Co., Ltd. announced that it has launched the Equfina® 50mg TABLETS (safinamide mesila...

November 25, 2019 | Monday | News
Astellas and Welldoc collaborate for digital therapeutics

Japan headquartered Astellas Pharma Inc. and US based Welldoc, Inc. have entered into a collaboration and license agreem...

November 22, 2019 | Friday | News
Japan grants ODD to Merck's investigational therapy Tepotinib

Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare ...

November 21, 2019 | Thursday | News
Toray signs pact with JICA to support infection control capacity

Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA)...

November 20, 2019 | Wednesday | News
Novartis to buy Aspen’s Japanese operations

Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business o...

November 18, 2019 | Monday | News
Lupin bids goodbye to Japan

Indian pharma major Lupin Limited (including its subsidiaries, together referred to as  ‘Lupin’) a...

November 18, 2019 | Monday | News
Clinical Trial of Boron Neutron Capture Therapy commences in Japan

Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Bo...

November 18, 2019 | Monday | News
Takeda announces 12 new molecular entities

Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to ou...

November 15, 2019 | Friday | News
NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...

November 15, 2019 | Friday | News
Yokogawa acquires nanopipette technology for life science applications

Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was devel...

November 14, 2019 | Thursday | News
Novo Nordisk obtains worldwide licence to potential NASH candidate

Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an ...

November 8, 2019 | Friday | News
Takeda, Anderson Cancer Center accelerate cell therapy

University of Texas MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center) and Takeda P...

November 12, 2019 | Tuesday | News
Kayentis opens Japanese subsidiary

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) solutions for clinical trials, has announce...

November 11, 2019 | Monday | News
Fujitsu improves efficiency in Cancer Genomic Medicine in joint AI research

Fujitsu, on 7 Nov 2019, announced the results of a joint research project it has been conducting with the Institute of M...

November 8, 2019 | Friday | News
Takeda’s Dengue vaccine candidate reveals protection in children

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...

November 8, 2019 | Friday | News
Hitachi collaborates with CLB to fight cancer using AI

Tokyo headquartered Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-Fra...

November 7, 2019 | Thursday | News
Olympus unveils corporate strategy

Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's e...

November 7, 2019 | Thursday | News